Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04265378
Other study ID # AD-Stim
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2019
Est. completion date October 10, 2022

Study information

Verified date November 2022
Source University Medicine Greifswald
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate whether a tDCS-accompanied intensive cognitive training of working memory leads to performance improvement in individuals with prodromal Alzheimer's disease.


Description:

The goal of the present study is to assess behavioral (primary) effects of a multi-session cognitive training combined with transcranial direct current stimulation (tDCS). Many studies to date have found tDCS to be an efficient method to enhance various cognitive functions by modulating cortical excitability in young adults, but its behavioral impact and underlying mechanisms in pathological aging still need to be elucidated. Individuals with prodromal Alzheimer's disease, will participate in a three-week cognitive training with concurrent online tDCS application. Cognitive performance (primary) will be examined before, during and after the intervention, in order to draw conclusions about the effect of tDCS. In addition to cognitive training, a control group, receiving sham stimulation during training, will be assessed. Follow-up sessions to assess long-term effects are planned four weeks and seven months after the post assessment. Furthermore, to assess potential predictors of tDCS effects, functional and structural parameters will be measured with MRI. The results of the study will offer valuable insights into efficacy of combined tDCS and cognitive training, as compared to training alone, in individuals with prodromal stages of Alzheimer's disease. Moreover, improved understanding of tDCS effects on cognitive training performance and underlying neural correlates may help to develop novel approaches for modulating cognitive decline in healthy and pathological aging.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date October 10, 2022
Est. primary completion date October 10, 2022
Accepts healthy volunteers No
Gender All
Age group 60 Years to 80 Years
Eligibility Inclusion Criteria: - Older adults (60 - 80 years); - Right handedness; - subjective cognitive decline (SCD) or mild cognitive impairment (MCI) Exclusion Criteria: - Dementia or other neurodegenerative neurological disorders; epilepsy or history of seizures; close relatives with epilepsy or history of seizures; previous stroke; - Severe and untreated medical conditions that precludes participation in the training, as determined by responsible physician; - History of severe alcoholism or use of drugs; - Severe psychiatric disorders such as depression (if not in remission) or psychosis

Study Design


Intervention

Device:
anodal tDCS
Anodal transcranial direct current stimulation (tDCS), 9 sessions with 20 minutes stimulation each (current intensity of 1mA)
Behavioral:
Intensive cognitive training
Intensive cognitive training of a letter memory updating task and a 3-stage Markov decision making task, 9 sessions

Locations

Country Name City State
Germany University Medicine Greifswald Greifswald

Sponsors (1)

Lead Sponsor Collaborator
University Medicine Greifswald

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Working memory training performance (Letter Updating task) Performance in a memory training task (Letter updating) under anodal tDCS compared to sham condition; operationalized by working Memory Updating performance assessed with number of correctly recalled letter lists in the letter updating task, analyzed immediately after training period (anodal condition versus sham) 3 weeks
Secondary Working memory training performance (Markov task) Performance in second memory training task (Markov decision making) under anodal tDCS compared to sham condition, analyzed immediately after training period (anodal condition versus sham) 3 weeks
Secondary Transfer outcomes: numerical n-back task (% correct) Comparing performance immediately before and after training period (anodal condition versus sham) 3 weeks
Secondary Transfer outcomes: AVLT (auditory verbal learning test) (sum of correctly recalled items trials 1-5) Comparing performance immediately before and after training period (anodal condition versus sham) 3 weeks
Secondary Transfer outcomes: Wiener Matrices Test (no. correct) Comparing performance immediately before and after training period (anodal condition versus sham) 3 weeks
Secondary Long-term outcomes: Letter Updating task (no. of correctly recalled lists) Comparing performance immediately before and after training period with performance at 4 weeks and 7-months after training period (anodal condition versus sham) 4 weeks and 7 months after training
Secondary Long-term outcomes: Markov decision making task (% optimal actions) Comparing performance immediately before and after training period with performance at 4 weeks and 7-months after training period (anodal condition versus sham) 4 weeks and 7 months after training
Secondary Long-term outcomes: numerical n-back task (% correct) Comparing performance immediately before and after training period with performance at 4 weeks and 7-months after training period (anodal condition versus sham) 4 weeks and 7 months after training
Secondary Long-term outcomes: AVLT (auditory verbal learning test) (sum of correctly recalled items trials 1-5) Comparing performance immediately before and after training period with performance at 4 weeks and 7-months after training period (anodal condition versus sham) 4 weeks and 7 months after training
Secondary Long-term outcomes: Wiener Matrices Test (no. correct) Comparing performance immediately before and after training period with performance at 4 weeks and 7-months after training period (anodal condition versus sham) 4 weeks and 7 months after training
Secondary Neural correlates: Structural neural correlates of tDCS effect - structural neural correlates; assessed by grey matter volumes, cortical thickness, white matter microstructure (diffusion tensor imaging (DTI) measures: fractional anisotropy, mean diffusivity)
before the intervention and at 7-months after training period (correlations in anodal group)
before training; 7 months after training
Secondary Neural correlates: Functional neural correlates of tDCS effect - functional neural correlates; assessed by resting-state fMRI analyses to obtain functional connectivities (seed-based connectivity: correlation of BOLD-timeseries between a seed/ROI and every voxel/location in the brain)
before the intervention and at 7-months after training period (correlations in anodal group)
before training; 7 months after training
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A